Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics
The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …
Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C
C Vollbracht, K Kraft - Frontiers in Pharmacology, 2022 - frontiersin.org
Oxidative stress is a pivotal point in the pathophysiology of COVID-19 and presumably also
in Long-COVID. Inflammation and oxidative stress are mutually reinforcing each other, thus …
in Long-COVID. Inflammation and oxidative stress are mutually reinforcing each other, thus …
Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on …
E Cenko, L Badimon, R Bugiardini… - Cardiovascular …, 2021 - academic.oup.com
The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
[HTML][HTML] COVID-19 a triggering factor of autoimmune and multi-inflammatory diseases
EK Sher, A Ćosović, A Džidić-Krivić, EK Farhat, E Pinjić… - Life sciences, 2023 - Elsevier
SARS-Cov-2 virus has attracted a lot of attention globally, due to the autoimmune and
inflammatory processes that were observed during the development of Covid-19 disease …
inflammatory processes that were observed during the development of Covid-19 disease …
Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality
A Aleksova, AL Fluca, G Gagno, A Pierri, L Padoan… - Life sciences, 2022 - Elsevier
Since the very beginning of the coronavirus disease 2019 (COVID-19) pandemic in early
2020, it was evident that patients with cardiovascular disease (CVD) were at an increased …
2020, it was evident that patients with cardiovascular disease (CVD) were at an increased …
Tissue factor in COVID-19-associated coagulopathy
Evidence of micro-and macro-thrombi in the arteries and veins of critically ill COVID-19
patients and in autopsies highlight the occurrence of COVID-19-associated coagulopathy …
patients and in autopsies highlight the occurrence of COVID-19-associated coagulopathy …
What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms
Abstract Background Coronavirus disease 19 (COVID-19) is the disease caused by SARS-
CoV-2, a highly infectious member of the coronavirus family, which emerged in December …
CoV-2, a highly infectious member of the coronavirus family, which emerged in December …
Autoimmunity roots of the thrombotic events after COVID-19 vaccination
Although vaccination represents the most promising way to stop or contain the coronavirus
disease 2019 (COVID-19) pandemic and safety and effectiveness of available vaccines …
disease 2019 (COVID-19) pandemic and safety and effectiveness of available vaccines …
COVID‐19‐induced autoimmune thyroiditis: Exploring molecular mechanisms
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) damages multiple
organs, including the thyroid, by direct invasion and cell entry via angiotensin‐converting …
organs, including the thyroid, by direct invasion and cell entry via angiotensin‐converting …
COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment
L Ortega-Paz, AH Talasaz… - … in thrombosis and …, 2023 - thieme-connect.com
COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …